1. World Health Organization. Sugars intake for adults and children. Geneva: World Health Organization;2015.
2. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet. 1999; 354(9179):617–621.
3. Beisswenger P, Heine RJ, Leiter LA, Moses A, Tuomilehto J. Prandial glucose regulation in the glucose triad: emerging evidence and insights. Endocrine. 2004; 25(3):195–202.
Article
4. Jenkins DJ, Wolever TM, Collier GR, Ocana A, Rao AV, Buckley G, Lam Y, Mayer A, Thompson LU. Metabolic effects of a low-glycemic-index diet. Am J Clin Nutr. 1987; 46(6):968–975.
Article
5. Riccardi G, Rivellese AA, Giacco R. Role of glycemic index and glycemic load in the healthy state, in prediabetes, and in diabetes. Am J Clin Nutr. 2008; 87(1):269S–274S.
Article
6. McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PW, Jacques PF. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care. 2004; 27(2):538–546.
Article
7. Ludwig DS, Majzoub JA, Al-Zahrani A, Dallal GE, Blanco I, Roberts SB. High glycemic index foods, overeating, and obesity. Pediatrics. 1999; 103(3):E26.
Article
8. Korea Health Industry Development Institute. Sugar database compilation for commonly consumed foods. Cheongju: Ministry of Food and Drug Safety;2015.
9. Latulippe ME, Skoog SM. Fructose malabsorption and intolerance: effects of fructose with and without simultaneous glucose ingestion. Crit Rev Food Sci Nutr. 2011; 51(7):583–592.
Article
10. DeChristopher LR, Uribarri J, Tucker KL. Intake of high fructose corn syrup sweetened soft drinks, fruit drinks and apple juice is associated with prevalent coronary heart disease, in U.S. adults, ages 45–59 y. BMC Nutr. 2017; 3(1):51.
Article
11. Ibarra-Reynoso LDR, López-Lemus HL, Garay-Sevilla ME, Malacara JM. Effect of restriction of foods with high fructose corn syrup content on metabolic indices and fatty liver in obese children. Obes Facts. 2017; 10(4):332–340.
Article
12. Kim JH. Spotlight functional sweeteners. Food Ind Nutr. 2010; 15(2):26–28.
14. Bierman EL, Baker EM, Plough IC, Hall WH. Metabolism of dribose in diabetes mellitus. Diabetes. 1959; 8(6):455–458.
Article
15. Steinberg T, Poucher RL, Sarin RK, Rees RB, Gwinup G. Oral administration of D-ribose in diabetes mellitus. Diabetes. 1970; 19(1):11–16.
Article
16. Han C, Lu Y, Wei Y, Liu Y, He R. D-ribose induces cellular protein glycation and impairs mouse spatial cognition. PLoS One. 2011; 6(9):e24623.
Article
17. Hetenyi G Jr, Ishiwata K. Effect of D-(--)-ribose on the turnover of glucose in dogs. Am J Physiol. 1968; 214(6):1333–1339.
Article
18. Ishiwata K, Hetenyi G Jr, Vranic M. Effect of D-glucose or D-ribose on the turnover of glucose in pancreatectomized dogs maintained on a matched intraportal infusion of insulin. Diabetes. 1969; 18(12):820–827.
Article
19. Ismail ZB, Abu-Baker N, Alzoubi K, Al-Zhgoul M, Al-Essa MK, Khlouf S, Al-Saleh A, Al-Omari B, Abu-Tayeh R, Shomaf M, Battah A, Al-Hadidi K. Evaluation of alpha-D-ribofuranose (D-ribose) toxicity after intravenous administration to rabbits. Hum Exp Toxicol. 2012; 31(8):820–829.
20. Teitelbaum JE, Johnson C, St Cyr J. The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. J Altern Complement Med. 2006; 12(9):857–862.
Article
21. Seifert JG, Subudhi AW, Fu MX, Riska KL, John JC, Shecterle LM, St Cyr JA. The role of ribose on oxidative stress during hypoxic exercise: a pilot study. J Med Food. 2009; 12(3):690–693.
Article
22. Lee YH, Shin KO, Kim KS, Kim YI, Woo JH. The effects of D-ribose supplementation on the production of blood fatigue factors after maximal intensity exercise. J Life Sci. 2011; 21(5):729–733.
Article
23. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002; 76(1):5–56.
Article
24. Brouns F, Bjorck I, Frayn KN, Gibbs AL, Lang V, Slama G, Wolever TM. Glycaemic index methodology. Nutr Res Rev. 2005; 18(1):145–171.
Article
25. Wolever TM, Vorster HH, Björck I, Brand-Miller J, Brighenti F, Mann JI, Ramdath DD, Granfeldt Y, Holt S, Perry TL, Venter C, Xiaomei Wu. Determination of the glycaemic index of foods: interlaboratory study. Eur J Clin Nutr. 2003; 57(3):475–482.
Article
26. Nam H, Kyung M, Seo S, Jung S, Chang MJ. Effect of different levels of xylooligosaccharide in sugar on glycemic index and blood glucose response in healthy adults. J Nutr Health. 2015; 48(5):398–406.
Article
27. Moon SH, Lee KS, Kyung MO, Jung SW, Park YJ, Yang CK. Study on the proper D-xylose concentration in sugar mixture to reduce glycemic index (GI) value in the human clinical model. Korean J Food Nutr. 2012; 25(4):787–792.
Article
28. Lee JS, Kim AR, Nam H, Kyung M, Seo S, Chang MJ. Effect of varying levels of xylobiose in sugar on glycemic index and blood glucose response in healthy adults. J Nutr Health. 2016; 49(5):295–303.
Article
29. Brand-Miller JC, Holt SH, Pawlak DB, McMillan J. Glycemic index and obesity. Am J Clin Nutr. 2002; 76(1):281S–285S.
Article
30. Hodge AM, English DR, O'Dea K, Giles GG. Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care. 2004; 27(11):2701–2706.
Article
31. Ludwig DS. Dietary glycemic index and obesity. J Nutr. 2000; 130:2S Suppl. 280S–283S.
Article
32. Pliml W, von Arnim T, Stäblein A, Hofmann H, Zimmer HG, Erdmann E. Effects of ribose on exercise-induced ischaemia in stable coronary artery disease. Lancet. 1992; 340(8818):507–510.
Article
33. Gross M, Zöllner N. Serum levels of glucose, insulin, and C-peptide during long-term D-ribose administration in man. Klin Wochenschr. 1991; 69(1):31–36.
Article
34. Tao SU, Rong-Qiao HE. An insight of D-ribose metabolic imbalance in Type 2 diabetes mellitus. Prog Biochem Biophys. 2015; 42(4):390–392.
35. Bae YJ, Bak YK, Kim B, Kim MS, Lee JH, Sung MK. Coconut-derived D-xylose affects postprandial glucose and insulin responses in healthy individuals. Nutr Res Pract. 2011; 5(6):533–539.
Article
36. Shibanuma K, Degawa Y, Houda K. Determination of the transient period of the EIS complex and investigation of the suppression of blood glucose levels by L-arabinose in healthy adults. Eur J Nutr. 2011; 50(6):447–453.
Article
37. Seri K, Sanai K, Matsuo N, Kawakubo K, Xue C, Inoue S. L-arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals. Metabolism. 1996; 45(11):1368–1374.
Article
38. Segal S, Foley J. The metabolism of D-ribose in man. J Clin Invest. 1958; 37(5):719–735.
Article
39. Sahlin K, Broberg S, Ren JM. Formation of inosine monophosphate (IMP) in human skeletal muscle during incremental dynamic exercise. Acta Physiol Scand. 1989; 136(2):193–198.
Article
40. Naitö Y. Biochemical studies on d-ribose, with special reference to the mechanism of absorption of sugars from intestinal tract. J Biochem. 1944; 36(1):131–161.
41. Griffiths JC, Borzelleca JF, St Cyr J. Sub-chronic (13-week) oral toxicity study with D-ribose in Wistar rats. Food Chem Toxicol. 2007; 45(1):144–152.
Article
42. Eijnde BO, Van Leemputte M, Brouns F, Van Der Vusse GJ, Labarque V, Ramaekers M, Van Schuylenberg R, Verbessem P, Wijnen H, Hespel P. No effects of oral ribose supplementation on repeated maximal exercise and de novo ATP resynthesis. J Appl Physiol (1985). 2001; 91(5):2275–2281.
43. Yoon JW, Lee SE, Park H. Effect of D-ribose supplementation on run-to-exhaustion time and antioxidative capacity under sea level or high altitude condition. J Exerc Nutr Biochem. 2009; 13(1):45–50.
44. Shecterle LM, St Cyr JA. Dermal benefits of topical D-ribose. Clin Cosmet Investig Dermatol. 2009; 2:151–152.
46. Su T, He R. D-ribose, an overlooked player in type 2 diabetes mellitus? Sci China Life Sci. 2014; 57(3):361.
Article
47. Seifert J, Frelich A, Shecterle L, St Cyr J. Assessment of hematological and biochemical parameters with extended D-ribose ingestion. J Int Soc Sports Nutr. 2008; 5(1):13.
Article
48. Ministry of Food and Drug Safety (KO). The first comprehensive plan for the sugar reduction ('16-'20). Cheongju: Ministry of Food and Drug Safety;2016.